ATC code P: Difference between revisions
Content deleted Content added
m +pl: |
m →top: Shortened short description Tags: Mobile edit Mobile app edit Android app edit |
||
| (41 intermediate revisions by 33 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Section of ATC Classification for antiparasitics, insecticides, and repellents.}} |
|||
A section of the [[Anatomical Therapeutic Chemical Classification System]]. |
|||
| ⚫ | |||
==References== |
|||
| ⚫ | |||
{{Reflist}} |
|||
:[[ATC code P01|P01 Antiprotozoals]] |
|||
:[[ATC code P02|P02 Anthelmintics]] |
|||
:[[ATC code P03|P03 Ectoparasiticides, including scabicides, insecticides and repellents]] |
|||
{{Major drug groups}} |
|||
| ⚫ | |||
{{Antiprotozoal agent}} |
|||
{{Excavata antiparasitics}} |
|||
[[fr:ATC code P]] |
|||
{{Agents against amoebozoa}} |
|||
[[pl:ATC (P)]] |
|||
{{Anthelmintics}} |
|||
{{Ectoparasiticides}} |
|||
{{Insecticides}} |
|||
| ⚫ | |||
Latest revision as of 14:31, 22 August 2023
| ATC code P: Antiparasitic products, insecticides and repellents |
|---|
| Human only |
|
| ATCvet only |
|
| Other ATC codes |
ATC code P Antiparasitic products, insecticides and repellents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3][4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code P". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
|---|---|
| gastrointestinal tract / metabolism (A) | |
| blood and blood forming organs (B) | |
| cardiovascular system (C) | |
| skin (D) | |
| genitourinary system (G) | |
| endocrine system (H) | |
| infections and infestations (J, P, QI) | |
| malignant disease (L01–L02) | |
| immune disease (L03–L04) | |
| muscles, bones, and joints (M) | |
| brain and nervous system (N) |
|
| respiratory system (R) | |
| sensory organs (S) | |
| other ATC (V) | |
